Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.
Lakefront Biotherapeutics - Sponsored ADR (LKFT) Earnings per Share (EPS) (Diluted) data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Earnings per Share (EPS) (Diluted) |
-- |
| Balance Sheet Financials | |
$2.69B |
|
$89.39M |
|
$1.21B |
|
$3.90B |
|
$81.77M |
|
$5.55M |
|
$20.04M |
|
$101.80M |
|
$3.79B |
|
$2.92B |
|
$3.79B |
|
-- |
|
| Cash Flow Statement Financials | |
$-135.85M |
|
$189.42M |
|
$-5.17M |
|
$102.16M |
|
$158.07M |
|
$55.91M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|